Skip to main content
Clinical Trials/NCT00593762
NCT00593762
Suspended
Not Applicable

Investigation of Laboratory Resistance to Aspirin and Clopidogrel and Its Clinical Relevance in Patients With Peripheral Arterial Occlusive Disease Requiring Interventional Procedures

Johann Wolfgang Goethe University Hospital1 site in 1 country200 target enrollmentMay 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Peripheral Arterial Occlusive Disease
Sponsor
Johann Wolfgang Goethe University Hospital
Enrollment
200
Locations
1
Primary Endpoint
Need for peripheral arterial revascularisation
Status
Suspended
Last Updated
16 years ago

Overview

Brief Summary

The purpose of the study is to determine the response to aspirin (ASA) and Clopidogrel in patients with peripheral arterial occlusive disease (PAOD) requiring interventional procedures and to investigate if patients with "resistance" to ASA or Clopidogrel have an unfavourable outcome during long-term follow-up

Registry
clinicaltrials.gov
Start Date
May 2005
End Date
December 2009
Last Updated
16 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Johann Wolfgang Goethe University Hospital

Eligibility Criteria

Inclusion Criteria

  • PAOD patients
  • Age 18-85 years
  • Need for a catheter interventional procedure
  • Antithrombotic therapy with aspirin or clopidogrel

Exclusion Criteria

  • Comedication additionally compromising platelet function
  • Known bleeding disorder
  • Life expectancy \< 6 months

Outcomes

Primary Outcomes

Need for peripheral arterial revascularisation

Time Frame: 1, 6, 12 and 24 months

Secondary Outcomes

  • Cardiovascular events (death, myocardial infarction, stroke, ACS, PCI)(1, 6, 12 and 24 months)

Study Sites (1)

Loading locations...

Similar Trials